Table 1.
Baseline Characteristics of Nevirapine-Unexposed Infants
| Characteristic (N=19) | Median (IQR) or n (%) |
|---|---|
| Infant characteristics | |
| Female | 8 (42) |
| Age at enrollment, months | 3.8 (2.4–4.2) |
| Weight-for-age z-score (WAZ) | −3.21 (−3.73–−1.34) |
| Height-for-age z-score (HAZ) | −2.12 (−3.25–−0.93) |
| Weight-for-height z-score (WHZ) | −0.88 (−3.07–0.12) |
| HIV WHO Clinical Stage III/IV | 10 (53) |
| CD4+ T cells, % | 19 (15–25) |
| CD4+ T cell count, cells/μl | 1,311 (760–1,939) |
| Plasma HIV-1 RNA, copies/mla | 5,300,000 (1,280,450–9,189,600) |
| Plasma HIV-1 RNA, log10 copies/mla | 6.72 (6.11–6.96) |
| HIV-1 subtype | |
| A | 12 (63) |
| C | 3 (16) |
| D | 2 (11) |
| Recombinant | 2 (11) |
| ART regimen | |
| NVP/3TC/AZT | 17 (89) |
| NVP/3TC/ABC | 2 (11) |
| Maternal characteristics | |
| Age, years | 25 (23–31) |
| Secondary or college education | 11 (58) |
| Housewife or unemployed | 18 (95) |
| CD4+ T cell count, cells/μlb | 417 (201–486) |
| On ARV regimen | 1 (5) |
| Breastfeeding | |
| Infant ever breastfed | 18 (95) |
| Duration of breastfeeding, monthsc | 10 (6–15) |
a
Information was unavailable for two mother–infant pairs.
b
Information was unavailable for one mother–infant pair.
c
Three mothers reported ever breastfeeding their infants, but did not report the duration of breastfeeding.